Drug safety amendments of 1976 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session ...

The safety and effectiveness of new drugs (market withdrawal of drugs containing cyclamates) : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 3, 1971.
Published: (1971)

Generic animal drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, second session, on H.R. 5069 ... July 29, 1986.
Published: (1987)

The safety and effectiveness of new drugs (standards for evaluating drug effectiveness--enforcement problems) : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 5, 1971.
Published: (1971)

The safety and effectiveness of new drugs (advertising and promotion of prescription drugs) : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, first session. May 4, 1971.
Published: (1971)

Drug regulation reform act of 1978 : hearings before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 11611 and all other similar and identical bills ...
Published: (1978)

Drug Enforcement Administration authorization : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, on H.R. 3036 ... March 21, 1979.
Published: (1979)

FDA's regulation of the drug "Triazure" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-fourth Congress, second session, October 27, 1976.
Published: (1976)

Drug safety : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2007)

Drug Enforcement Administration Authorization Act of 1977 : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, first session, on H.R. 5742 ... April 27, 1977.
Published: (1977)

Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965.
Published: (1965)

Monitoring for drug safety /
Published: (1986)

Drug Safety. hearings before the United States House Committee on Government Operations, Eighty-Ninth Congress, second session, on Mar. 9, 10, May 25, 26, June 7-9, 1966.
Published: (1966)

Drug Safety. hearings before the United States House Committee on Government Operations, Subcommittee on Intergovernmental Relations, Eighty-Ninth Congress, first session, on Mar. 23, 24, May 4, June 8-10, 24, 25, 1965.
Published: (1965)

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.
Published: (1983)

Review of transitional provisions in Drug amendments of 1962 : hearings, Ninety-second Congress, first session . /
Published: (1972)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991.
Published: (1991)

Drug efficacy : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-first Congress, first session.
Published: (1970)

Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2007)

Drug safety : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /
by: Crosse, Marcia
Published: (2008)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

Drug abuse control amendments--1970 : hearings, Ninety-first Congress, second session, on H.R. 11701 and H.R. 13743 ...
Published: (1970)

Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991.
Published: (1991)

Substitute prescription drug act : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, on H.R. 1963 ... June 22 and July 27, 1978.
Published: (1978)

Amendment to the Pure Food and Drugs Act : hearings before the United States House Committee on Interstate and Foreign Commerce, Sixtieth Congress, first session, on Jan. 17, 1908.
Published: (1908)

Communications act amendments of 1976 : hearing before the Subcommittee on Communications of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 10620 and S. 2343 ... July 29, 1976.
Published: (1976)

Drug Safety and Effectiveness : Issues and Action Options After FDA Approval.
Published: (2006)

Drug amendments of 1962.
Published: (1962)

H.R. 1963, the substitute prescription drug act : report of the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session.
Published: (1978)

Orphan Drug Act : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 7, 1990.
Published: (1990)

Discussion draft of the Food and Drug Administration Globalization Act legislation : drug safety : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 1, 2008.
Published: (2008)

Antitargets and drug safety /
Published: (2015)

Seizure of Foods and Drugs : hearings before the United States House Committee on Interstate and Foreign Commerce, Eightieth Congress, first session, on June 12, 1947.
Published: (1947)

Animal Drug Amendments of 1967 : hearings before the United States House Committee on Interstate and Foreign Commerce, Subcommittee on Public Health and Welfare, Ninetieth Congress, first session, on Oct. 3, 1967.
Published: (1967)

Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12, 2003.
Published: (2003)

Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12 2003.
Published: (2003)